Morgan Stanley reiterated its overweight rating on Dalmia Bharat, while Macquarie advised an outperform rating for Axis Bank. Jefferies sustained a hold rating on Kotak Mahindra Bank, and Investec endorsed a buy rating for Aurobindo Pharma.
OYO withdraws DRHP, to refile IPO post refinancing: Sources
Softbank-backed OYO is set to refile its much-awaited IPO as the global travel tech player is close to finalising its refinancing plans to raise up